Dr. Kaseko is honoured with an award at the 2nd International Conference on Cancer Immunotherapy & Immunomonitoring
During 2 to 5 May 2011, the 2nd International Conference on Cancer Immunotherapy & Immunomonitoring brought together an international cohort of scientists, clinicians, medical practitioners and students to discuss the latest therapeutic, preventative and diagnostic developments in the field. As SSRI’s submission to the conference, Dr. Kaseko together with the Institute’s scientific team prepared a poster on an efficient method of immortalising rare tumour B lymphocytes for identification of natural tumour specific antibodies. The Institute’s findings in this field open new avenues [...]